Filgrastim vs pegfilgrastim: A quality of life issue for children
Administration, safety, and efficacy are similar in both agents. However, the frequency of administration makes a significant difference for patients.
Administration, safety, and efficacy are similar in both agents. However, the frequency of administration makes a significant difference for patients.
Crizotinib active in anaplastic large cell lymphoma; neuroblastoma; other tumors with ALK mutations.
Updates to the scale ensure the questions are more accurate and relevant to pediatric cancer patients.
Pediatric patients with induction failure often present with high-risk features.
Stratification by age at diagnosis shows more mutations found in children diagnosed at an older age.
Cardiovascular abnormalities, markers of systemic inflammation and atherosclerotic disease seen
A two-session intervention might improve how well a youth adjusts to the cancer diagnosis of a brother or sister.
Tiny works of art are stringed together to tell a child’s story of courage during the course of treatment for cancer or another serious illness.
An incentive spirometer was the inspiration for a video game to help young cancer patients rebuild lung function.
Audiometric testing, awareness of the symptoms, and knowledge of which drugs are ototoxic can help protect young cancer patient’s hearing.